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Background: Decades after the eradication of smallpox, its etiological agent, variola virus
(VARV), remains a threat as a potential bioweapon. Outbreaks of smallpox around the
time of the global eradication effort exhibited variable case fatality rates (CFRs), likely
attributable in part to complex viral genetic determinants of smallpox virulence. We
aimed to identify genome-wide single nucleotide polymorphisms associated with CFR.
We evaluated unadjusted and outbreak geographic location-adjusted models of single
SNPs and two- and three-way interactions between SNPs.
Findings: Using the data mining approach multifactor dimensionality reduction
(MDR), we identified five VARV SNPs in models significantly associated with CFR. The
top performing unadjusted model and adjusted models both revealed the same
two-way gene-gene interaction. We discuss the biological plausibility of the
influence of the SNPs identified these and other significant models on the
strain-specific virulence of VARV.
Conclusions: We have identified genetic loci in the VARV genome that are
statistically associated with VARV virulence as measured by CFR. While our ability to
infer a causal relationship between the specific SNPs identified in our analysis and
VARV virulence is limited, our results suggest that smallpox severity is in part
associated with VARV strain variation and that VARV virulence may be determined
by multiple genetic loci. This study represents the first application of MDR to the
identification of pathogen gene-gene interactions for predicting infectious disease
outbreak severity.
Keywords: Smallpox, Variola virus, Single nucleotide polymorphisms, Multifactor
dimensionality reductionFindings
Smallpox, the only human infectious disease to have been eradicated, remains a threat
as a potential agent of bioterrorism. Mortality rates during natural outbreaks of small-
pox varied widely, a feature partially attributed to strain-specific virulence of the etio-
logical agent, the orthopoxvirus variola virus (VARV) [1]. An understanding of the
genetic determinants of virulence of VARV is critical for predicting the potential of dif-
ferent strains for causing severe epidemics.
We analyzed the genome-wide single nucleotide polymorphisms (SNPs) of a collec-
tion of 35 temporally, geographically and epidemiologically diverse VARV isolates
housed at the US Centers for Disease Control and Prevention’s secure repository (pre-
viously described in [2]) for associations with VARV virulence. We investigated the© 2013 Hoen et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.
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which range from <1-30% [2]. Previously, outbreaks of smallpox have been classified as
‘major’ when they exhibit greater than 10 percent CFRs. Because CFR can be
considered a complex phenotype of VARV that is likely mediated by, among other
factors, multiple viral genetic loci, we focused on identifying combinations of SNPs that
may interact in their associations with CFR. We used the non-parametric data mining
approach known as multifactor dimensionality reduction (MDR), described previously
[3]. Briefly, MDR evaluates candidate models based on all possible combinations of a
given number of SNPs and applies a naive Bayes classifier with cross-validation to esti-
mate the testing accuracy of each candidate model. The statistical significance of the
model that maximizes the testing accuracy is then assessed by permutation testing.
MDR has been used extensively to detect epistatic interactions in genome-wide associa-
tion studies of complex human diseases such as cancer, autism and cardiovascular di-
sease. This study is novel in its application of MDR to pathogen genome data.
From the full-genome sequences of the 35 isolates we studied, we identified 1730
SNPs using kSNP with k=25 [4]. We built a list of candidate SNPs for MDR analysis by
removing SNPs unlikely to have relevance to VARV virulence, including 979 synony-
mous SNPs and another 192 SNPs located in hypothetical proteins. Of the remaining
559 SNP loci, 126 were missing character states for one or more isolates. We
eliminated from our analysis 92 SNPs that were missing data for more than one isolate.
The remaining missing character states were imputed by replacing them with the most
commonly observed character state for that SNP. 345 SNPs with allele frequencies of
less than 10 percent (in fewer than 4 genomes) were also removed from the dataset,
leaving 122 candidate SNPs. We grouped SNP loci that were perfectly collinear, that is,
were in complete linkage disequilibrium in our sample of isolates. These loci are redun-
dant and impossible to distinguish in our models. This left us with 21 individual SNPs
or SNP groups as candidate attributes for our MDR models.
Our outcome of interest was CFR, coded as a binary variable where 0 represented
CFRs ≤ 10 percent and 1 represented CFRs > 10 percent. Of the 35 isolates, 18 were
associated with CFRs > 10 percent. Preliminary analyses revealed that CFR is signifi-
cantly associated with geographic location, namely, whether the outbreak occurred on
the African continent (Fisher’s exact test, p<0.001); therefore, in adjusted models we
included a binary covariate where 0 represented strains isolated from non-African
outbreaks and 1 represented strains isolated from African outbreaks. We fit one-way,
two-way and three-way SNP-SNP interaction models using MDR. All models were fit
using five-fold cross-validation and evaluated for significance using 1000 random
permutations [5].
Previous work has shown that these isolates form two major phylogenetic clades,
with the clade containing Asian and non-West African VARV variants, referred to as
primary clade I in [6], exhibiting different biological properties than the clade
containing West African and South American variants [6,7]. Accordingly, we
investigated the sensitivity of our modeling approach to phylogenetic differences by
performing the same analysis on the set of isolates belonging to primary clade I. This
model could not be adjusted for a geographic association between CFR and African
origin because CFR and geographic origin are perfectly correlated among isolates in
this clade.
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significantly predict smallpox CFR (Table 1). SNPs are hereafter referred to by their
positions in the genome of the reference strain gi|94484460|gb|DQ441420.1| Variola
virus strain Bangladesh 1974 (nur islam). These SNPs represent loci in 19 different
VARV genes (Table 2). We used testing balanced accuracy, a measure of model accur-
acy that avoids inflating performance estimates due to unbalanced data to measure the
performance of each model. The same two-way SNP-SNP interaction was identified
in both the top-performing unadjusted and adjusted models (Table 1). The top-
performing unadjusted model slightly outperformed the corresponding adjusted model;
however, the difference in model testing balanced accuracy was small and both models
were significant. When we restricted our analysis to only the isolates in primary clade I,
we identified two models with equal testing balanced accuracy values, a two-way model
and a three-way model. However, the two-way model performed better was more con-
sistently selected in cross-validation. In all three analyses, the top-performing model
revealed the same two-way effect of an interaction between SNP 127469 and one or
more SNPs in group 1 on CFR.
SNP 127469 was involved in all models with the exception of the one-way unadjusted
models. This SNP falls within the gene encoding the cowpox A-type inclusion protein.
In some orthopoxviruses, the A-type inclusion protein forms inclusion bodies in the
cytoplasm of infected cells, into which mature virus particles are embedded. The pre-
sence of inclusion bodies probably enhances survival and dissemination in the environ-
ment [8,9]. VARV, like other orthopoxviruses, has a conserved A-type inclusion protein
gene; however, VARV-infected cells accumulate large quantities of the protein without
forming typical inclusion bodies, which suggests that it may have some other function.
The A-type inclusion protein has been shown in the prototypical orthopoxvirus vac-
cinia virus to be highly immunogenic, and variants of vaccinia with mutations in the
A-type inclusion protein gene exhibit reduced immunogenicity [10].
The other variable in our top models, group 1, represents a group of 4 perfectly col-
linear SNPs that cannot be distinguished among the strains in our sample. SNP 28347
falls within a gene for a serine/threonine kinase that phosphorylates virion proteinsTable 1 Summary of models evaluated by MDR for predicting smallpox outbreak CFRs
using VARV SNPs
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CVC: cross valid consistency.
Table 2 SNPs identified in MDR analysis of associations between VARV genetic variation
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1 28347 A/G ABG43202 E/K 296 Ser\Thr kinase Phosphorylates virion
proteins involved in
assembly








and needed for actin
tail formation













2 6738 G/T ABG43172 D/A 169 Ankyrin-like
protein
Unknown
7008 T/C ABG43172 K/R 79 Ankyrin-like
protein
Unknown
8300 T/C ABG43175 D/N 111 Ankyrin-like
protein
Unknown
8333 G/T ABG43175 N/H 100 Ankyrin-like
protein
Unknown





















143136 T/C ABG43324 H/R 197 Hydroxysteroid
dehydrogenase
Steroid biosynthesis




150364 T/C ABG43334 S/L 57 Kelch-like ring
canal protein
Unknown
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Table 2 SNPs identified in MDR analysis of associations between VARV genetic variation
and smallpox outbreak CFRs (Continued)
162026* T/C ABG43349 Q/* 105 Ser/Thr kinase-
like protein
Unknown





N/A 42293 G/A ABG43215 E/G 147 IMV protein Unknown






IEV: intracellular enveloped virion; IMV: intracellular mature virion.
*SNP is in two overlapping open reading frames.
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clusion protein. SNP 136573 is a polymorphism in the gene encoding A36R, a trans-
membrane phosphoprotein of the intracellular enveloped virion (IEV) form. The IEV is
the precursor to the extracellular cell-associated enveloped virion, which requires this
protein for producing the actin tails that push it away from the cell surface and allow it
to disseminate to adjacent cells. Loss of A36R results in a small plaque phenotype
in vitro and in reduced virulence in vivo [11]. SNP 151088 is a locus in the gene for the
hemagglutinin protein. It is found in the extracellular enveloped virus form of VARV.
In the vaccinia virus model, in which it is known as the A56 protein, it is able to bind
two viral proteins, K2, a serine protease inhibitor, and VCP, the vaccinia virus comple-
ment control protein, to the surface of infected host cells. With A56, K2 reduces the
amount of virus superinfecting an infected cell and prevents the fusion of infected cells,
while the VCP complex inhibits complement activity. Deletion of this gene impacts vac-
cinia virus virulence [12].
Other models identified by our MDR analysis performed inferiorly to these; however,
they allowed us to identify SNPs that were significantly associated with CFR. SNP
183083 was found in two relatively high-performing models, both the one-way and
three-way unadjusted models. This SNP is in the gene for the CrmB secreted TNF-
alpha-receptor-like protein. This is a TNF-alpha receptor expressed by poxviruses that
blocks cytokine activity to interfere with the host immune function, thereby enhancing
viral virulence [13]. Additional SNPs identified in our analysis are shown in Table 2 and
include loci in genes that encode additional host defense modulators and proteins cri-
tical to the viral life cycle.
This study represents a novel application of MDR to studying pathogen genome-wide
associations with infectious disease outbreak severity. Of the models we evaluated using
MDR, the best-performing model predicted smallpox outbreak CFR with a two-way
VARV gene-gene interaction. While we are limited in our ability to infer a causal rela-
tionship between the interacting SNPs identified in our analysis and smallpox outbreak
severity, the genes implicated have potential biological plausibility as determinants of
VARV virulence and may represent targets for future laboratory-based investigations.
The results of this study reinforce existing evidence that smallpox outbreak severity
may be in part a consequence of the VARV strain associated with the outbreak and
suggests that VARV virulence is a complex trait influenced by multiple genetic loci.
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